{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:44:21Z","timestamp":1787168661177,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01673"],"award-info":[{"award-number":["PI16\/01673"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01272"],"award-info":[{"award-number":["PI13\/01272"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00593"],"award-info":[{"award-number":["PI19\/00593"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10072-022-06102-y","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T15:31:57Z","timestamp":1651851117000},"page":"5057-5065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-1903","authenticated-orcid":false,"given":"Maria","family":"Salvado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7299-1796","authenticated-orcid":false,"given":"Cecilia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Rudilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-7944","authenticated-orcid":false,"given":"Laura","family":"Zalba-Jadraque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-1363","authenticated-orcid":false,"given":"Eva","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-7486","authenticated-orcid":false,"given":"Josep","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5667-4133","authenticated-orcid":false,"given":"Jose Manuel","family":"Vidal-Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"6102_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archneur.1971.00490010059009","volume":"25","author":"T Namba","year":"1971","unstructured":"Namba T, Brunner NG, Brown SB et al (1971) Familial myasthenia gravis: report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol 25:49\u201360. https:\/\/doi.org\/10.1001\/archneur.1971.00490010059009","journal-title":"Arch Neurol"},{"key":"6102_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0317167100001050","volume":"27","author":"RA Marrie","year":"2000","unstructured":"Marrie RA, Sahlas DJ, Bray GM (2000) Familial autoimmune myasthenia gravis: four patients involving three generations. Can J Neurol Sci 27:307\u2013310. https:\/\/doi.org\/10.1017\/S0317167100001050","journal-title":"Can J Neurol Sci"},{"key":"6102_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nmd.2011.10.004","volume":"22","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wang W, Wei D, Yang L (2012) Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies. Neuromuscul Disord 22:286\u2013288. https:\/\/doi.org\/10.1016\/j.nmd.2011.10.004","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"6102_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/cells8070671","volume":"8","author":"I Koneczny","year":"2019","unstructured":"Koneczny I, Herbst R (2019) Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture. Cells 8(7):671. https:\/\/doi.org\/10.3390\/cells8070671","journal-title":"Cells"},{"issue":"11","key":"6102_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","volume":"14","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 14(11):212. https:\/\/doi.org\/10.3389\/fimmu.2020.00212","journal-title":"Front Immunol"},{"key":"6102_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475\u2013490. https:\/\/doi.org\/10.1016\/S1474-4422(09)70063-8","journal-title":"Lancet Neurol"},{"key":"6102_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1405.027","volume":"1132","author":"M Giraud","year":"2008","unstructured":"Giraud M, Vandiedonck C, Garchon HJ (2008) Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 1132:180\u2013192. https:\/\/doi.org\/10.1196\/annals.1405.027","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"6102_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102349","volume":"18","author":"H Zhong","year":"2019","unstructured":"Zhong H, Zhao C, Luo S (2019) HLA in myasthenia gravis: from superficial correlation to underlying mechanism. Autoimmun Rev 18(9):102349. https:\/\/doi.org\/10.1016\/j.autrev.2019.102349","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6102_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13317-019-0124-6","volume":"11","author":"S Mu\u00f1iz-Castrillo","year":"2020","unstructured":"Mu\u00f1iz-Castrillo S, Vogrig A, Honnorat J (2020) Associations between HLA and autoimmune neurological diseases with autoantibodies. Autoimmun Highlights 11(1):2. https:\/\/doi.org\/10.1186\/s13317-019-0124-6","journal-title":"Autoimmun Highlights"},{"key":"6102_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.coi.2004.07.014","volume":"16","author":"CE Larsen","year":"2004","unstructured":"Larsen CE, Alper CA (2004) The genetics of HLA-associated disease. Curr Opin Immunol 16:660\u2013667. https:\/\/doi.org\/10.1016\/j.coi.2004.07.014","journal-title":"Curr Opin Immunol"},{"key":"6102_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1399-0039.1978.tb01347.x","volume":"12","author":"F Naeim","year":"1978","unstructured":"Naeim F, Keesey JC, Herrmann C et al (1978) Association of HLA\u2014B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis. Tissue Antigens 12:381\u2013386. https:\/\/doi.org\/10.1111\/j.1399-0039.1978.tb01347.x","journal-title":"Tissue Antigens"},{"key":"6102_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.ge.15.120181.001125","volume":"15","author":"LP Ryder","year":"2003","unstructured":"Ryder LP, Svejgaard A, Dausset J (2003) Genetics of HLA disease association. Annu Rev Genet 15:169\u2013187. https:\/\/doi.org\/10.1146\/annurev.ge.15.120181.001125","journal-title":"Annu Rev Genet"},{"key":"6102_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1399-0039.1994.tb02291.x","volume":"43","author":"A Svejgaard","year":"1994","unstructured":"Svejgaard A, Ryder LP (1994) HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18\u201327. https:\/\/doi.org\/10.1111\/j.1399-0039.1994.tb02291.x","journal-title":"Tissue Antigens"},{"key":"6102_CR14","doi-asserted-by":"publisher","unstructured":"(IMSGC) TIMSGC, (WTCCC2) WTCCC 2, Sawcer S, et al (2012) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214\u2013219. https:\/\/doi.org\/10.1038\/nature10251.Genetic","DOI":"10.1038\/nature10251.Genetic"},{"issue":"10","key":"6102_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ng.3395","volume":"47","author":"L Moutsianas","year":"2015","unstructured":"Moutsianas L, Jostins L, Beecham AH et al (2015) Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet 47(10):1107\u20131113. https:\/\/doi.org\/10.1038\/ng.3395","journal-title":"Nat Genet"},{"key":"6102_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","volume":"166\u2013167","author":"G Saruhan-Direskeneli","year":"2016","unstructured":"Saruhan-Direskeneli G, Hughes T, Yilmaz V et al (2016) Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clin Immunol 166\u2013167:81\u201388. https:\/\/doi.org\/10.1016\/j.clim.2016.05.003","journal-title":"Clin Immunol"},{"key":"6102_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1756286419864497","volume":"383","author":"J Gamez","year":"2019","unstructured":"Gamez J, Salvad\u00f3 M, Carmona F et al (2019) Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis. Ther Adv Neurol Disord 383:118\u2013122. https:\/\/doi.org\/10.1177\/1756286419864497","journal-title":"Ther Adv Neurol Disord"},{"key":"6102_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","volume":"55","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Neurology 55:16\u201323. https:\/\/doi.org\/10.1212\/wnl.55.1.16","journal-title":"Neurology"},{"issue":"4","key":"6102_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/tan.13644","volume":"94","author":"E Enrich","year":"2019","unstructured":"Enrich E, Campos E, Martorell L et al (2019) HLA-A, -B, -C, -DRB1, and -DQB1 allele and haplotype frequencies: an analysis of umbilical cord blood units at the Barcelona Cord Blood Bank. HLA 94(4):347\u2013359. https:\/\/doi.org\/10.1111\/tan.13644","journal-title":"HLA"},{"key":"6102_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mus.23964","volume":"48","author":"NM Alkhawajah","year":"2013","unstructured":"Alkhawajah NM, Oger J (2013) Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve 48:705\u2013710. https:\/\/doi.org\/10.1002\/mus.23964","journal-title":"Muscle Nerve"},{"key":"6102_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.humimm.2015.12.006","volume":"77","author":"DJ Pappas","year":"2016","unstructured":"Pappas DJ, Marin W, Hollenbach JA, Mack SJ (2016) Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): an integrated case-control analysis pipeline. Hum Immunol 77:283\u2013287. https:\/\/doi.org\/10.1016\/j.humimm.2015.12.006","journal-title":"Hum Immunol"},{"key":"6102_CR22","doi-asserted-by":"publisher","unstructured":"Gauderman WJ (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21(1):35-50. https:\/\/doi.org\/10.1002\/sim.973","DOI":"10.1002\/sim.973"},{"key":"6102_CR23","unstructured":"Yousefipour GA, Salami Z, Farjadian S (2009) Association of HLADQA1* 0101\/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients. Iran J Immunol 6(2):99\u2013102. https:\/\/iji.sums.ac.ir\/?sid=Entrez:PubMed&id=pmid:19561379&key=2009.6.2.99,\u00a0https:\/\/iji.sums.ac.ir\/articl_17080_31d1b7a151ba8b666a264d0cc96d90c5.pdf"},{"key":"6102_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","volume":"67","author":"G Saruhan-Direskeneli","year":"2006","unstructured":"Saruhan-Direskeneli G, Kili\u00e7 A, Parman Y et al (2006) HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum Immunol 67:352\u2013358. https:\/\/doi.org\/10.1016\/j.humimm.2006.02.039","journal-title":"Hum Immunol"},{"key":"6102_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/541760","volume":"1","author":"M Testi","year":"2012","unstructured":"Testi M, Terracciano C, Guagnano A et al (2012) Association of HLA-DQB1*05:02 and DRB1*16 alleles with late-onset, nonthymomatous. AChR-Ab-positive myasthenia gravis Autoimmune Dis 1:541760. https:\/\/doi.org\/10.1155\/2012\/541760","journal-title":"AChR-Ab-positive myasthenia gravis Autoimmune Dis"},{"key":"6102_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2011.08.023","volume":"312","author":"H Yang","year":"2012","unstructured":"Yang H, Hao J, Peng X et al (2012) The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients. J Neurol Sci 312:57\u201361. https:\/\/doi.org\/10.1016\/j.jns.2011.08.023","journal-title":"J Neurol Sci"},{"key":"6102_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/08916939409008008","volume":"19","author":"T Horiki","year":"1994","unstructured":"Horiki T, Inoko H, Moriuchi J et al (1994) Combinations of HLA-DPBl and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan. Autoimmunity 19:49\u201354. https:\/\/doi.org\/10.3109\/08916939409008008","journal-title":"Autoimmunity"},{"key":"6102_CR28","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jocn.2011.05.002","volume":"18","author":"YC Xie","year":"2011","unstructured":"Xie YC, Qu Y, Sun L et al (2011) Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population. J Clin Neurosci 18:1524\u20131527. https:\/\/doi.org\/10.1016\/j.jocn.2011.05.002","journal-title":"J Clin Neurosci"},{"key":"6102_CR29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","volume":"57","author":"M Giraud","year":"2001","unstructured":"Giraud M, Beaurain G, Yamamoto AM et al (2001) Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 57:1555\u20131560. https:\/\/doi.org\/10.1212\/WNL.57.9.1555","journal-title":"Neurology"},{"issue":"5","key":"6102_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10072-019-04213-7","volume":"41","author":"CS Ling","year":"2020","unstructured":"Ling CS, Shen ML, Wang Y et al (2020) The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis. Neurol Sci 41(5):1041\u20131049. https:\/\/doi.org\/10.1007\/s10072-019-04213-7","journal-title":"Neurol Sci"},{"key":"6102_CR31","doi-asserted-by":"publisher","unstructured":"Maniaol AH, Elsais A, Lorentzen \u00c5R, et al (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the norwegian population. PLoS One 7(5) https:\/\/doi.org\/10.1371\/journal.pone.0036603","DOI":"10.1371\/journal.pone.0036603"},{"key":"6102_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(74)92548-3","volume":"303","author":"D Fritze","year":"1974","unstructured":"Fritze D, Naeim F, Herrman C et al (1974) HL-A antigens in myasthenia gravis. Lancet 303:240\u2013243. https:\/\/doi.org\/10.1016\/S0140-6736(74)92548-3","journal-title":"Lancet"},{"key":"6102_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0165-5728(93)90021-P","volume":"47","author":"M Vieira","year":"1993","unstructured":"Vieira M, Caillat-Zucman S, Gajdos P et al (1993) Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J Neuroimmunol 47:115\u2013122. https:\/\/doi.org\/10.1016\/0165-5728(93)90021-P","journal-title":"J Neuroimmunol"},{"key":"6102_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/08916939508995300","volume":"22","author":"P Hjelmstr\u00f6m","year":"1995","unstructured":"Hjelmstr\u00f6m P, Giscombe R, Lefvert AK et al (1995) Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis. Autoimmunity 22:59\u201365. https:\/\/doi.org\/10.3109\/08916939508995300","journal-title":"Autoimmunity"},{"issue":"3","key":"6102_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/acn3.51309","volume":"8","author":"G Spagni","year":"2021","unstructured":"Spagni G, Todi L, Monte G et al (2021) Human leukocyte antigen class II associations in late-onset myasthenia gravis. Ann Clin Transl Neurol 8(3):656\u2013665. https:\/\/doi.org\/10.1002\/acn3.51309","journal-title":"Ann Clin Transl Neurol"},{"key":"6102_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","volume":"72","author":"PK Gregersen","year":"2012","unstructured":"Gregersen PK, Kosoy R, Lee AT et al (2012) Risk for myasthenia gravis maps to a 151Pro\u2192Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72:927\u2013935. https:\/\/doi.org\/10.1002\/ana.23691","journal-title":"Ann Neurol"},{"key":"6102_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/brain\/103.3.579","volume":"103","author":"DAS Compston","year":"1980","unstructured":"Compston DAS, Vincent A, Newsom-davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579\u2013601. https:\/\/doi.org\/10.1093\/brain\/103.3.579","journal-title":"Brain"},{"key":"6102_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1399-0039.1991.tb01851.x","volume":"37","author":"A Spurkland","year":"1991","unstructured":"Spurkland A, Gilhus NE, R\u00f8nningen KS et al (1991) Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens 37:90\u201393. https:\/\/doi.org\/10.1111\/j.1399-0039.1991.tb01851.x","journal-title":"Tissue Antigens"},{"key":"6102_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jneuroim.2012.03.018","volume":"247","author":"W-H Zhu","year":"2012","unstructured":"Zhu W-H, Lu J-H, Lin J et al (2012) HLA-DQA1*03:02\/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese. J Neuroimmunol 247:81\u201385. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.018","journal-title":"J Neuroimmunol"},{"key":"6102_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jns.2015.11.021","volume":"359","author":"S Ehsan","year":"2015","unstructured":"Ehsan S, Amirzargar A, Yekaninejad MS et al (2015) Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population. J Neurol Sci 359:335\u2013342. https:\/\/doi.org\/10.1016\/j.jns.2015.11.021","journal-title":"J Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06102-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T09:16:49Z","timestamp":1659518209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06102-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6102"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06102-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committees (IRB) of Vall d'Hebron Hospital Universitari (PR(AG)20\/2018) and Catalan Transplant Organization approved this study. All patients agreed to participate in this study and gave permission for blood sampling via written informed consent in accordance with the approved\u00a0protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}